DataSheet_1_Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50.pdf by András L. Kovács (13565251)

“…Whole exome sequencing identified a previously not described hemizygous nonsense variant (c.650G>A, p.W217X) within exon 6 of the moesin (MSN) gene localized on chromosome X, resulting in significantly decreased MSN mRNA expression compared to healthy controls. …”

Decreased spacing with different numbers of branches to enhance green fig production by Rafael Pio (4618255)

“…The spacing of 0.50 m decreases production per plant, but increases yield in 73%. …”

Table_2_Move for Life an intervention for inactive adults aged 50 years and older: a cluster randomised feasibility trial.DOCX by Catherine B. Woods (10517765)

“…Background<p>Move for Life (MFL) is a theory-informed intervention that was developed to augment established physical activity (PA) programmes and enable inactive adults aged 50 years and older to be more active. …”

Table_1_Move for Life an intervention for inactive adults aged 50 years and older: a cluster randomised feasibility trial.DOCX by Catherine B. Woods (10517765)

“…Background<p>Move for Life (MFL) is a theory-informed intervention that was developed to augment established physical activity (PA) programmes and enable inactive adults aged 50 years and older to be more active. …”

Parallel group trials and cross-over trials: Risk of decreased appetite. by Mathilde Holmskov (4112062)

Supplementary Material for: Decreases in Brain Size and Encephalization in Anatomically Modern Humans by Stibel J.M. (11623042)

“…Growth in human brain size and encephalization is well documented throughout much of prehistory and believed to be responsible for increasing cognitive faculties. Over the past 50,000 years, however, both body size and brain mass have decreased but little is known about the scaling relationship between the two. …”

table2_CYP2D6 Genetic Variation and Its Implication for Vivax Malaria Treatment in Madagascar.xlsx by Rajeev K. Mehlotra (3211350)

“…In a total of 211 samples collected from two health districts, CYP2D6 decreased function alleles CYP2D6*10, *17, *29, *36+*10, and *41 were observed at frequencies of 3.55–17.06%. …”

Co-expression of WT with M195T–WT decreases the stability of heteromers. by Cinzia Ambrosi (446348)

MβCD treatment of cultured ORNs decreases EGFR labeling. by Nicholas J. Gibson (173220)

Standardized prevalence* HADS-D>=8 with 95% CI by sex, time, age group, and living situation. by Maria Lage Barca (4515385)

Standardized prevalence* of depression (HADS-D>=8) with 95% CI by sex, age, and self-reported loneliness. by Maria Lage Barca (4515385)

Table2_Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients.XLSX by Yang Zhao (39052)

“…We have newly identified systemic site-specific N-glycosylation alterations underlying T2D patients in the complement activation pathways, including decreased levels of N-glycopeptides from C1s, MASP1, and CFP proteins, and increased levels of N-glycopeptides from C2, C4, C4BPA, C4BPB, and CFH. …”

Parallel group trials: Risk of decreased appetite according to dose of methylphenidate. by Mathilde Holmskov (4112062)

PEITC inhibits PTP1B with concomitant decrease in cysteinyl thiol. by Miho Yagi (5921252)

Sox6 overexpression decreased the multi-lineage differentiation potential in NSPCs. by Shigeki Ohta (233204)

HRs, 95% CIs, and <i>p</i>-values for the association of duration of lithium exposure with the development of dementia (and its subtypes) by Cox proportional hazards models. by Shanquan Chen (3417512)

Subjects:

Avertin®-induced decrease in basal particle transport speed (PTS) remains unaffected in WT mice in the presence of TASK-1 inhibitors and in TASK-1 KO mice. by Ghulam Murtaza (2559319)

Bioavailable copper levels can be decreased in vivo by copper chelating agents. by Andrew Crowe (450839)

Forest plot of the differences of fasting blood glucose (mg/dL) within 4 months between <i>Curcuma longa</i> (CL) supplementation and control group. by Thanika Pathomwichaiwat (16625189)

Subgroup analysis of difference of fasting blood glucose (mg/dL) within 4 months between <i>Curcuma longa</i> (CL) supplementation and control group. by Thanika Pathomwichaiwat (16625189)